Drug user

Results: 1369



#Item
361Pharmaceutical sciences / New Drug Application / Debarment / Center for Biologics Evaluation and Research / Federal Food /  Drug /  and Cosmetic Act / Biologic License Application / Investigational New Drug / Prescription Drug User Fee Act / Criticism of the Food and Drug Administration / Food and Drug Administration / Medicine / Health

[removed]Federal Register / Vol. 73, No[removed]Monday, November 24, [removed]Notices Section 903(b)(2)(c) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 393(b)(2)(c)) authorizes FDA to

Add to Reading List

Source URL: www.fda.gov.

Language: English
362Health / Pharmaceutical sciences / Prescription Drug User Fee Act / Priority review voucher / New Drug Application / Federal Food /  Drug /  and Cosmetic Act / Pharmaceutical industry / Center for Devices and Radiological Health / Generic drug / Food and Drug Administration / Medicine / Pharmaceuticals policy

FDASIA Small Business Report

Add to Reading List

Source URL: www.fda.gov.

Language: English
363Pharmacology / Pharmaceutical sciences / Biosimilar / Biotechnology / Drugs / Biologic / Center for Biologics Evaluation and Research / Center for Drug Evaluation and Research / Food and Drug Administration / Clinical research / Medicine

Public Stakeholder Meeting on Biosimilars User Fee Program, June 24, 2011

Add to Reading List

Source URL: www.fda.gov

Language: English
364Pharmaceuticals policy / Pharmaceutical industry / Clinical pharmacology / Food and Drug Administration / United States Public Health Service / Generic drug / User fee / Animal drugs / Drug Enforcement Administration / Pharmaceutical sciences / Pharmacology / Clinical research

THE SECRETARY OF HEALTH AND HUMAN SERVICES WASHINGTON. D.C[removed]JUL[removed]The Honorable Edward M. Kennedy Chairman

Add to Reading List

Source URL: www.fda.gov.

Language: English
365Food and Drug Administration / Pharmaceuticals policy / Therapeutics / United States Public Health Service / Pharmaceutical industry / Off-label use / Methadone / Prescription Drug User Fee Act / Orphan drug / Pharmacology / Pharmaceutical sciences / Clinical research

July 25, 2014 The Honorable Fred Upton, Chairman U.S. House of Representatives Committee on Energy & Commerce 2125 Rayburn House Office Building

Add to Reading List

Source URL: www.rarediseases.org

Language: English - Date: 2014-07-28 12:01:38
366Pharmaceuticals policy / Pharmacology / Safety / Clinical pharmacology / United States Public Health Service / Prescription Drug User Fee Act / Risk assessment / Food and Drug Administration / Pharmaceutical sciences / Risk

Benefit-risk balance assessment during life cycle of medicinal products

Add to Reading List

Source URL: www.fda.gov.

Language: English
367Pharmaceutical industry / Pharmaceutics / Food and Drug Administration / Bioequivalence / Pharmacokinetics / Generic drug / Abbreviated New Drug Application / NIPTE / Center for Drug Evaluation and Research / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy

Generic Drug User Fee Amendments of 2012 Regulatory Science Initiatives:

Add to Reading List

Source URL: www.fda.gov

Language: English
368Pharmacology / Pharmaceutical industry / Therapeutics / United States Public Health Service / Center for Drug Evaluation and Research / Drug development / Prescription Drug User Fee Act / California Institute for Quantitative Biosciences / Biosimilar / Food and Drug Administration / Pharmaceutical sciences / Clinical research

OCP Update May 4, 2012 PhRMA IQC

Add to Reading List

Source URL: www.fda.gov

Language: English
369Pharmaceutical sciences / Medicine / Prescription Drug User Fee Act / Electronic Common Technical Document / Regulated Product Submissions / Food and Drug Administration / Pharmaceuticals policy / Health

PDUFA IV IT PLAN ABBREVIATED UPDATE MAY 2010

Add to Reading List

Source URL: www.fda.gov

Language: English
370Chemistry / Carbamates / Pyridines / United States Public Health Service / New Drug Application / Prescription Drug User Fee Act / Vorapaxar / Food and Drug Administration / Pharmaceutical sciences / Pharmacology

FDA Briefing Document Addendum for the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) Meeting Date: 15 January 2014

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE